Medicrea’s CEO acquires 90k shares — 3 points

Medicrea disclosed Chairman and CEO Denys Sournac purchasing company shares.

Advertisement

Here are three points:

 

1. Mr. Sournac acquired 90,045 shares between Jan. 22 and Jan. 25.

 

2. Medicrea focuses on devolving products for personalized spine surgery, based on a data-driven and system-based approach.

 

3. The company develops spinal implant technologies that surgeons have used in 150,000-plus procedures.

 

More articles on devices:
Zimmer Biomet generates $7.8B in 2017 sales, spine segment sees 14% growth
Smith & Nephew opens specialized operations center in Costa Rica: 4 highlights
Dr. Michael Ries publishes book on inventing new hip, knee replacement devices — 5 highlights

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.